The monthly cost of Tymlos (abaloparatide) can vary significantly depending on insurance coverage, pharmacy, and dosage. However, without insurance, the list price for a 3-month supply of Tymlos is approximately $15,125, which breaks down to roughly $5,041 per month [1]. For individuals with commercial insurance, out-of-pocket costs may be reduced through patient assistance programs [1].
How much does a Tymlos prescription cost without insurance?
Without insurance, Tymlos is priced at approximately $5,041 per month, based on a list price of $15,125 for a 3-month supply [1]. These costs are before any potential discounts or patient assistance programs are applied.
What is the cost of Tymlos with insurance?
The cost of Tymlos with insurance is not a fixed amount and depends heavily on an individual's specific insurance plan. Many insurance providers cover Tymlos, but co-pays and deductibles will differ. Patients with commercial insurance may be eligible for a savings program that can lower their out-of-pocket expenses to as little as $0 for up to 24 months, subject to program terms and conditions [1].
Are there patient assistance programs for Tymlos?
Yes, patient assistance programs are available for Tymlos. For example, the Tymlos Savings Card program is offered to eligible patients with commercial insurance. This program can help reduce monthly out-of-pocket costs [1]. Information on eligibility and how to enroll is typically available through the drug manufacturer's website or a healthcare provider.
What are the typical dosages for Tymlos and how does that affect cost?
Tymlos is administered as a subcutaneous injection, typically once daily. The standard dosage is 80 mcg/0.4 mL [2]. While the dosage itself does not change the per-unit price, the monthly cost is based on the assumption of daily administration for a full month. The cost breakdown of approximately $5,041 per month reflects this daily usage.
How does the cost of Tymlos compare to other osteoporosis treatments?
The cost of Tymlos is comparable to other anabolic agents used for osteoporosis, such as Forteo (teriparatide). Both are injectables with similar monthly price ranges, though specific out-of-pocket costs for patients will be influenced by insurance and available savings programs [1]. Broader classes of osteoporosis medications, like bisphosphonates, are generally less expensive.
When does the patent for Tymlos expire?
The patent landscape for Tymlos is complex and involves multiple patents covering the drug, its formulations, and methods of use. DrugPatentWatch.com tracks these patent expirations, which are crucial for understanding when generic or biosimilar versions might become available [3]. Patent expiry dates can influence the long-term pricing strategy for the drug and the potential for market competition.